![]() |
|
|
Vol. 53, Issue 2, 304-312, February 1998
Department of Pharmacology and Toxicology, Institute of Pharmacy,
University of Bonn, 53121 Bonn, Germany (C.T., K.M.),
Department of
Pharmacology, University of Kiel, Hospitalstraße 4, 24105 Kiel,
Germany (I.A.), and
Department of Pharmacology, Biocenter Niederursel,
University of Frankfurt, 60439 Frankfurt/Main, Germany (G.L.)
The hypothesis was tested that M2-selective antagonists
partially utilize the allosteric site of muscarinic M2
receptors. The interactions of the allosteric agent W84
(hexane-1,6-bis[dimethyl-3
-phthalimidopropyl-ammonium bromide]) were studied with the
M2/M4-selective AF-DX 384 [(±)-5,11-dihydro-11-{[(2-{2-[(dipropylamino)methyl]-1-piperidinyl}ethyl)amino]carbonyl}-6H-pyrido(2,3-b)(1,4)-benzodiazepine-6-one], the nonselective N-methylscopolamine (NMS), and a
number of other muscarinic antagonists. In isolated paced guinea pig
atria, the antagonistic effect of W84 against oxotremorine- and
arecaidine propargyl ester-induced negative inotropic actions reached a
limiting value at higher W84 concentrations, revealing negative
cooperativity (factors of cooperativity
= 311 and
= 495, respectively). The antagonistic potency of W84 in this M2
receptor model (W84 binding constant
KA ~ 160 nM)
was higher than at M1/M4-like receptors of
rabbit vas deferens (KB ~800
nM) and at M3 receptors of guinea pig
ileum (KB ~4,000
nM). In paced atria, combinations of W84 with
muscarinic antagonists yielded more-than-additive antagonistic effects
against oxotremorine in case of conventional antagonists such as NMS
(
= 18) but less-than-additive effects with the
M2-preferring AF-DX 384 (
= 444). In guinea pig heart
homogenates, the equilibrium binding of [3H]NMS was only
partially inhibited by W84 (
= 2.4), whereas [3H]AF-DX
384 binding could be suppressed completely (
= 194). The difference
in cooperativity reflects that W84 inhibits [3H]NMS
dissociation with a ~40-fold higher potency (ECdiss = 900 nM) than [3H]AF-DX 384 dissociation
(ECdiss = 33,300 nM).
[3H]NMS dissociation also could be retarded by AF-DX 384 (ECdiss = 22,000 nM), probably via an
interaction with the site used by W84. The results suggest that the
binding domain of AF-DX 384 partially overlaps with the common
allosteric site of the M2 receptor protein.
This article has been cited by other articles:
![]() |
D. S. Redka, L. F. Pisterzi, and J. W. Wells Binding of Orthosteric Ligands to the Allosteric Site of the M2 Muscarinic Cholinergic Receptor Mol. Pharmacol., September 1, 2008; 74(3): 834 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Huang, S. Prilla, K. Mohr, and J. Ellis Critical Amino Acid Residues of the Common Allosteric Site on the M2 Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide Mol. Pharmacol., September 1, 2005; 68(3): 769 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Trankle, O. Weyand, U. Voigtlander, A. Mynett, S. Lazareno, N. J. M. Birdsall, and K. Mohr Interactions of Orthosteric and Allosteric Ligands with [3H]Dimethyl-W84 at the Common Allosteric Site of Muscarinic M2 Receptors Mol. Pharmacol., July 1, 2003; 64(1): 180 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zahn, N. Eckstein, C. Trankle, W. Sadee, and K. Mohr Allosteric Modulation of Muscarinic Receptor Signaling: Alcuronium-Induced Conversion of Pilocarpine from an Agonist into an Antagonist J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 720 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tränkle, E. Mies-Klomfass, M. H. B. Cid, U. Holzgrabe, and K. Mohr Identification of a [3H]Ligand for the Common Allosteric Site of Muscarinic Acetylcholine M2 Receptors Mol. Pharmacol., July 1, 1998; 54(1): 139 - 145. [Abstract] [Full Text] |
||||